SNWV (SANUWAVE Health) Dividends Paid

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SNWV SANUWAVE Health Inc SNWV
29 GF Score
Price $4.48
GF Value $13.66
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is SANUWAVE Health Dividends Paid?

Dividends Paid only applicable to companies reporting Cash Flow from Operations in direct method.

SNWV
29GF Score
SANUWAVE Health Inc SNWV
Dividends Paid is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is SANUWAVE Health (SNWV) Overvalued in 2026?

Based on GuruFocus' analysis, SANUWAVE Health stock appears to be undervalued. The current stock price of $4.48 is trading 67.2% below its estimated GF Value™ of $13.66. GuruFocus considers SANUWAVE Health to be Possible Value Trap.

Key valuation signals for SNWV:

  • Dividends Paid:
  • GF Value™: $13.66 vs. price of $4.48 (67.2% below fair value)
  • GF Score™: 29/100 with 7 warning signs

No single metric tells the full story. See the SNWV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SANUWAVE Health Business Description

Address 9600 W. 76th Street, Suite 118, Eden Prairie, MN, USA, 55344
SANUWAVE Health Inc is a US-based medical device company focused on wound care. Its primary commercial product is the UltraMIST System, an FDA-cleared noninvasive ultrasound device that delivers low-frequency, non-contact ultrasound energy to treat acute and chronic wounds, including diabetic foot ulcers, pressure ulcers, and venous stasis ulcers. The company also develops regenerative medicine technologies using extracorporeal shock waves to promote tissue repair and regeneration. SANUWAVE sells its devices and related consumables, such as single-use applicators, primarily to hospitals, wound care clinics, and long-term care facilities, generating recurring revenue through consumable sales. It operates in one reportable segment, the design, development, and sale of medical devices. The company generates the majority of its revenue in the United States, with additional sales in select international markets.
29GF Score

Get the complete analysis for SNWV

Dividends Paid is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.48
Price
$13.66
GF Value